Bioerodible matrix for tissue involvement

US10898607B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10898607-B2
Application numberUS-201615373666-A
CountryUS
Kind codeB2
Filing dateDec 9, 2016
Priority dateMar 27, 2009
Publication dateJan 26, 2021
Grant dateJan 26, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are polyurethane polymer matrices with a porosity of from about 20 microns to about 90 microns that are useful in promoting closure and protection of incision sites; supporting the lower pole position of breast implants; and providing a partial or complete covering of breast implants to provide a beneficial interface with host tissue and to reduce the potential for malpositioning or capsular contracture. The disclosed matrices can be seeded with mammalian cells.

First claim

Opening claim text (preview).

What is claimed is: 1. A medical implant comprising: a breast prosthesis; and a matrix on said breast prosthesis, the matrix comprising a resorbable or bioerodible polymer component and a cellular component, wherein the polymer component comprises polycaprolactone soft segments having an amorphous rubbery phase, the matrix having a porosity conducive to cell growth and capable of providing a beneficial interface between the prosthesis and host tissue to enhance biocompatibility and reducing the potential for malpositioning or capsular contracture. 2. The implant of claim 1 wherein the cellular component comprises stem cells. 3. The implant of claim 1 wherein the cellular component comprises adipose cells. 4. The implant of claim 1 wherein the cellular component comprises stem cells and adipose cells. 5. The implant of claim 1 wherein the matrix forms at least a partial covering on said breast prosthesis. 6. The implant of claim 1 wherein the matrix forms a complete covering of said breast prosthesis. 7. The implant of claim 1 wherein the matrix has a pore size diameter of about 10 to about 1000 microns. 8. The implant of claim 1 wherein the matrix has a pore size diameter of from about 20 to about 90 microns.

Assignees

Inventors

Classifications

  • characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel · CPC title

  • Porous materials, {e.g. foams or sponges} · CPC title

  • comprising two or more cell types · CPC title

  • Mammary prostheses · CPC title

  • characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10898607B2 cover?
Disclosed herein are polyurethane polymer matrices with a porosity of from about 20 microns to about 90 microns that are useful in promoting closure and protection of incision sites; supporting the lower pole position of breast implants; and providing a partial or complete covering of breast implants to provide a beneficial interface with host tissue and to reduce the potential for malpositioni…
Who is the assignee on this patent?
Allergan Inc
What technology area does this patent fall under?
Primary CPC classification A61L27/18. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 11 related publications on this page (citations in our corpus or others sharing the same primary CPC).